Lazard has advised on its third mergers and acquisitions deal in a week with a role on the Sfr3.3bn (€2.2bn) acquisition of Centerpulse, the Swiss medical technology company.
The bank lined up with bidder Smith & Nephew (S&N), the Anglo-American medical devices group, while Lehman and UBS Warburg represented Centerpulse.